TipRanks
Go Ultimate55% OFF
PC:BIO06

Biomatter: Valuation, Funding & Investors

Biomatter is a Lithuania-based biotechnology company developing an AI-first platform for on-demand enzyme design to support biotech and pharmaceutical R&D. Its Intelligent Architecture™ combines generative models, including ProteinGAN, with physics-based engines to design functional enzymes rapidly, aiming to accelerate product development and reduce timelines.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$7M
Total Funding Rounds
1
Latest Funding Amount
$7M
Latest Funding Round
Seed Round

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jun 02, 2026Seed Round$6.50M―

Similar Companies

A snapshot of private companies similar to Biomatter, helping you discover and navigate related company profiles.

Related News and Analysis